Chronic obstructive pulmonary disease is one of the leading causes of morbidity and
mortality worldwide and a growing healthcare problem. Identification of modifiable risk …

In order to clarify the possible role of N-acetylcysteine (NAC) in the treatment of patients with
chronic bronchitis and chronic obstructive pulmonary disease (COPD), we have carried out …

Background Treatment guidelines recommend the use of inhaled long-acting
bronchodilators to alleviate symptoms and reduce the risk of exacerbations in patients with …

The quality of care can be improved by the development and implementation of evidence-
based treatment guidelines. Different national guidelines for chronic obstructive pulmonary …

Background Patients with COPD may share some clinical characteristics with asthma
sufferers. This phenotypic overlap between COPD and asthma is not yet well characterised …

Recognizing the clinical heterogeneity of COPD suggests a specific therapeutic approach
directed by the so-called clinical phenotypes of the disease. The Spanish COPD Guidelines …

Computed tomography scan images have been used to identify different radiological COPD
phenotypes based on the presence and severity of emphysema, bronchial wall thickening …

The new Global Initiative for Chronic Obstructive Lung Disease update has moved the
principles of treatment of stable chronic obstructive pulmonary disease (COPD) forward by …

COPD is now widely recognized as a complex heterogeneous syndrome, having both
pulmonary and extrapulmonary features. In clinical practice, the diagnosis of COPD is based …

The relevance of the ACOS is to identify patients with COPD who may have underlying
eosinophilic inflammation that responds to inhaled corticosteroids. So far, the previous …